Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), sold 279,600 shares at $17.00 ($4.8M) on 2025-06-04, disclosed to the SEC on 2025-06-05.
Open-market sale of $4.8M ETON by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.38 | 60,945 | $1.1M | 22.0% |
| 2 | $17.38 | 60,945 | $1.1M | 22.0% |
| 3 | $18.38 | 8,655 | $159K | 3.3% |
| 4 | $18.38 | 8,655 | $159K | 3.3% |
| 5 | $19.02 | 400 | $8K | 0.2% |
| 6 | $17.00 | 70,000 |
| $1.2M |
| 24.7% |
| 7 | $16.81 | 70,000 | $1.2M | 24.5% |
| Total | $17.21 avg | 279,600 | $4.8M | 100% |
| Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |
| ETON | BUY | 2021-06-03 | $30K | — | Filing → |